Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Additional genetic alterations in BRAF-mutant gliomas correlate with histologic diagnoses.

Journal of neuro-oncology - 1 Sept 2020

Dono Antonio, Vu Jennifer, Anapolsky Molly, Hines Gabriella, Takayasu Takeshi, Yan Yuanqing, Tandon Nitin, Zhu Jay-Jiguang, Bhattacharjee Meenakshi B, Esquenazi Yoshua, Ballester Leomar Y

Abstract excerpt

INTRODUCTION: Recently, the term "Diffuse glioma, BRAF V600E-mutant" has been recommended for IDH-wildtype gliomas with BRAF p.V600E mutation and without CDKN2A/B deletion. However, additional alterations in gliomas that coexist with BRAF-mutations are poorly defined. METHODS: We analyzed next-generation sequencing results in 315 cancer-associated genes for 372 gliomas from our institution (2010 to 2017). In...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Brain Neoplasms

Share to Follow-Up Studies

Share to Glioblastoma

Share to High-Throughput Nucleotide Sequencing

Share to Prognosis

Share to Proto-Oncogene Proteins B-raf

Source

Open in PubMed Open full text

Identifiers

PMID: 33009979
DOI: 10.1007/s11060-020-03634-1
PMCID: PMC7642042

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Additional genetic alterations in BRAF-mutant gliomas correlate with histologic diagnoses.PMID 33009979Read ↗

IDH-mutant gliomas with additional class-defining molecular events.Semantic proximity Read ↗

Molecular Pathology of Gliomas.Semantic proximity Read ↗

Molecular Pathology of Gliomas.Semantic proximity Read ↗

Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.Semantic proximity Read ↗

Molecular Testing of Brain TumorSemantic proximity Read ↗

BRAF V600E, TERT promoter mutations and CDKN2A/B homozygous deletions are frequent in epithelioid glioblastomas: a histological and molecular analysis focusing on intratumoral heterogeneity.Semantic proximity Read ↗

Molecular diagnostics of gliomas.Semantic proximity Read ↗

BRAF mutations may identify a clinically distinct subset of glioblastoma.Semantic proximity Read ↗

BRAFnon-V600E more frequently co-occurs with IDH1/2 mutation in adult patients with gliomas than patients harboring BRAFV600E, but without survival advantageSemantic proximity Read ↗

Molecular Genetics of GliomasSemantic proximity Read ↗

cIMPACT-NOW Update 12: Refining pathology-based risk stratification and grading for IDH-mutant gliomas.Semantic proximity Read ↗

Molecular Pathways in Gliomagenesis and Their Relevance to Neuropathologic DiagnosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.